Literature DB >> 7581337

Lipophosphoglycan is present in distinctly different form in different Entamoeba histolytica strains and absent in Entamoeba moshkovskii and Entamoeba invadens.

G Srivastava1, M T Anand, S Bhattacharya, A Bhattacharya.   

Abstract

Lipophosphoglycan has recently been demonstrated on the cell surface of Entamoeba histolytica strain HM-1:IMSS. A monoclonal antibody against this molecule had failed to react with some other strains of E. histolytica, including the strain Rahman. To determine if a structurally distinct lipophosphoglycan existed in Rahman, [3H]galactose-labeled glycoconjugates were electrophoresed through sodium dodecyl sulfate polyacrylamide gel electrophoresis. The electrophoretic pattern in Rahman was very different compared to that obtained with strains HM-1:IMSS and 200:NIH. A number of experiments including sensitivity to mild acid, nitrous acid and phosphoinositol-specific phospholipase C suggest that the Rahman glycoconjugate is indeed a lipophosphoglycan-like molecule but distinctly different from that of HM-1:IMSS. Mild acid-treated glycoconjugates from Rahman and HM-1:IMSS revealed the presence of neutral trisaccharides and monosaccharides in Rahman but not in HM-1:IMSS. Human immune sera from amoebiasis patients and a polyclonal antibody against HM-1:IMSS lipophosphoglycan both recognized Rahman glycoconjugate. Thus, while lipophosphoglycan molecules from the two strains share common epitopes, they are clearly distinct from each other. Molecules bearing resemblance to lipophosphoglycan could not be detected in other Entamoeba species, namely Entamoeba invadens and Entamoeba moshkovskii.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581337     DOI: 10.1111/j.1550-7408.1995.tb05916.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  5 in total

1.  Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.

Authors:  A Marinets; T Zhang; N Guillén; P Gounon; B Bohle; U Vollmann; O Scheiner; G Wiedermann; S L Stanley; M Duchêne
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

2.  Reduction of cell surface glycosylphosphatidylinositol conjugates in Entamoeba histolytica by antisense blocking of E. histolytica GlcNAc-phosphatidylinositol deacetylase expression: effect on cell proliferation, endocytosis, and adhesion to target cells.

Authors:  Divya Vats; Ram A Vishwakarma; Sudha Bhattacharya; Alok Bhattacharya
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  A Sequential Model of Host Cell Killing and Phagocytosis by Entamoeba histolytica.

Authors:  Adam Sateriale; Christopher D Huston
Journal:  J Parasitol Res       Date:  2011-01-20

4.  Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess.

Authors:  Hannelore Lotter; Nestor González-Roldán; Buko Lindner; Florian Winau; Armando Isibasi; Martha Moreno-Lafont; Artur J Ulmer; Otto Holst; Egbert Tannich; Thomas Jacobs
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

5.  Hypocholesterolemia in patients with an amebic liver abscess.

Authors:  María S Flores; Adriana Obregón-Cárdenas; Eva Tamez; Elba Rodríguez; Katiushka Arévalo; Isela Quintero; Rolando Tijerina; Francisco Bosques; Luis Galán
Journal:  Gut Liver       Date:  2014-04-23       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.